share_log

PsyKey Inc. Introduces Its Premium Functional Mushroom Infused Coffee Line to the $8 Billion Dollar Functional Mushroom Market, Through the Launch of Its New E-Commerce Website

PsyKey Inc. Introduces Its Premium Functional Mushroom Infused Coffee Line to the $8 Billion Dollar Functional Mushroom Market, Through the Launch of Its New E-Commerce Website

PsyKey Inc. 通過推出其新的電子商務網站,將其優質功能蘑菇注入咖啡線引入 80 億美元的功能蘑菇市場
Accesswire ·  2022/06/14 09:40

CARSON CITY, NV / ACCESSWIRE / June 14, 2022 / CECORS, INC. (OTC PINK:CEOS) ("CeCors", "PsyKey" or the "Company") is excited to announce it has completed the final production of its premium functional mushroom-infused coffee line and will launch its highly anticipated products in tandem with its new website and integrated e-commerce platform. The launch of the website will occur on Monday, June 20th, 2022.

內華達州卡森城/訪問線/2022 年 6 月 14 日/ 切科斯公司OTC PINK:首席執行官)(「Cecors」,「PsyKey」或「公司」)很高興地宣布,它已完成其高級功能蘑菇注入咖啡線的最終生產,並將與其新網站和集成電子商務平台一起推出其備受期待的產品。該網站的推出將於 2022 年 6 月 20 日(星期一)進行。

According to a report published by Allied Market Research, the global functional mushroom market generated $7.98 billion in 2020 and is estimated to reach $19.33 billion by 2030, witnessing a CAGR of 9.3% from 2021 to 2030.

根據聯合市場研究所發表的一份報告,全球功能性蘑菇市場在 2020 年產生 7.98 億美元,估計到 2030 年將達到 1933 億美元,見證 2021 年至 2030 年的複合年增長率達到 9.3%。

PsyKey has been working to establish four functional mushroom-infused coffees, which have been curated by combining 100% fair trade organic Arabica coffee beans with the full dried and ground fruiting body of adaptogenic, immune-boosting functional mushrooms that are both nutrient and antioxidant-rich. These mushroom varieties include Lions Mane, Turkey Tail, Chaga, Reishi, Cordyceps, and Maitake. The development of proprietary formulations and sourcing of premium quality bulk mushrooms for our products has been completed in partnership with MycoVita and renowned mycologist Dr. Omon Isikhuemhen. The four functional formulations that have been developed include, "MIND & MEMORY", "IMMUNE & DEFEND", "CALM & RELAXED", AND "REISHI GANO GOOD". Each functional coffee will be available to consumers in convenient single-serve coffee pods.

PsyKey 一直致力於開發四種功能性蘑菇注入的咖啡,這些咖啡是通過將 100% 公平貿易有機阿拉比卡咖啡豆與完整的乾燥和結實的適應原,提高免疫力的功能蘑菇結合而成,這些蘑菇既營養又富含抗氧化劑。這些蘑菇品種包括獅子鬃毛,土耳其尾巴,白樺茸,靈芝,蟲草和舞茸。專有配方和採購優質散裝蘑菇為我們的產品的開發已經完成了與 MyCoVita 和著名真菌學家博士.已經開發的四種功能配方包括:「心靈與記憶」,「免疫和防禦」,「平靜和放鬆」和「靈芝加諾良好」。每種功能性咖啡都可以在方便的單服務咖啡包中提供給消費者。

In conjunction with the completion of production, the Company will launch its new evolutionary website and direct-to-consumer e-commerce platform. During the development and production stages, the Company identified and engaged numerous distribution channels and potential key partnerships to support sales and build brand awareness. Initial product offerings will be available via the Company's e-commerce website, with additional distribution announcements soon to come.

隨著生產完成,公司將推出其新的進化網站和直接面向消費者的電子商務平台。在開發和生產階段,公司確定並參與了眾多分銷渠道和潛在的關鍵合作夥伴關係,以支持銷售並建立品牌知名度。初始產品將通過該公司的電子商務網站提供,並即將發布其他分銷公告。

"This has been an incredible journey from concept to commercialization. We can stand behind the quality and functionality of our first product offering with our premium single-serve coffees, which is the first in our brand portfolio," stated president Mr. Amar Bhatal. "We have taken our time to make sure that this coffee not only works, functionally but provides an incredible taste, something that stands out in the market. This is the first set of offerings in the portfolio - we have been developing other, various unique delivery systems for our proprietary formulations that we would look forward to offering to our consumers. A very exciting time to be a PsyKey shareholder," Continued Mr. Bhatal.

「這是從概念到商業化的令人難以置信的旅程。我們的優質單一咖啡可以支持我們第一款產品的質量和功能,這是我們品牌組合中的第一個產品。「我們花了時間來確保這種咖啡不僅在功能上起作用,而且提供了令人難以置信的味道,在市場上脫穎而出。這是該產品組合中的第一套產品-我們一直在為我們的專有配方開發其他各種獨特的交付系統,我們期待為我們的消費者提供。成為 PsyKey 股東的一個非常激動人心的時刻,」巴塔爾先生繼續說道。

For further information:

欲了解更多信息:

Publicly traded company (OTC PINK: CEOS)
Website:
E-mail: info@psykeyworld.com
Follow us on Twitter:

上市公司(場外粉紅:首席執行官)
網站:
電郵:info@psykeyworld.com
在推特上關注我們:

Forward-Looking Statements:

前瞻性陳述:

Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward- looking statements.

安全港聲明-除了歷史資訊外,本新聞稿還可能包含構成《1933 年證券法》和《1934 年證券交易法》所定義的前瞻性陳述,經 1995 年《私人證券訴訟改革法》修訂。本新聞稿中包含的前瞻性陳述包括本公司及其管理團隊成員對本公司未來業務運作的意圖、信念或期望,以及該等陳述所依據的假設。潛在投資者被警告,任何此類前瞻性陳述均不能保證未來 性能和性能和 涉及風險和不確定因素,而實際結果可能與該等前瞻性陳述所提出的結果有很大差異。可能導致這些差異的因素包括但不限於未能在談判下完成預期銷售、缺乏收入增長、客戶中斷、未能實現績效、效率和盈利能力的改進,以及涉及訴訟或訴訟成本增加、公司業務單位的營運或績效或其普通股的市場價格方面的不利發展。可能導致實際結果與本新聞稿中預期的結果有重大不同的其他因素,也可以在本公司的網站上找到。本公司概不負責更新任何前瞻性陳述。

SOURCE: CeCors, Inc.

來源: 中科斯公司


View source version on accesswire.com:
檢視網站上的原始碼版本:

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論